National Comprehensive Cancer Network



About NCCN

Central Nervous System Cancers Panel - Disclosures as of 2/28/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Mario Ammirati, MD, MBA

None

None

None

None

None

Henry Brem, MD

None

None

None

None

None

Paul Brown, MD

National Cancer Institute;
National Cancer Institute

Novocure

None

None

None

Nicholas Butowski, MD

None

Roche Laboratories, Inc.

None

None

None

Marc C. Chamberlain, MD

NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas

PharmacoKinesis Advisory Board

Roche Laboratories, Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

Lisa M. DeAngelis, MD

None

None

None

None

None

Robert A. Fenstermaker, MD

None

None

None

None

None

Allan Friedman, MD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Mark R. Gilbert, MD

RTOG Trial

Abbott Laboratories;
Genentech, Inc.;
Merck & Co., Inc.;
EMD Serono

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Jona Hattangadi-Gluth, MD

None

None

None

None

None

Deneen Hesser, MSHSA, RN, OCN

None

None

National Cancer Institute

None

None

Maria Ho, PhD

None

None

None

None

None

Matthias Holdhoff, MD, PhD

None

None

None

None

None

Larry Junck, MD

None

None

None

None

None

Ronald Lawson, MD, FACP

None

None

None

None

None

Jay S. Loeffler, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Nicole McMillian, MS

None

None

None

None

None

Paul L. Moots, MD

None

None

None

None

None

Maciej M. Mrugala, MD, PhD, MPH

None

Enzon Pharmaceuticals;
Schering-Plough Corporation

None

None

None

Louis Burt Nabors, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Merck KGaA;
Transmolecular

Merck KGaA

None

None

None

Herbert B. Newton, MD

None

Genentech, Inc.

Genentech, Inc.;
Genentech, Inc.

None

None

Jana Portnow, MD

None

None

None

None

None

Jeffrey J. Raizer, MD

None

Enzon Pharmaceuticals;
Genentech, Inc.;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

Genentech, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Agenus;
EMD Serano

None

None

Lawrence Recht, MD

None

Genentech, Inc.

None

None

None

Nicole Shonka, MD

None

Novocure advisory board

None

None

None

Dennis C. Shrieve, MD, PhD

None

None

None

None

None

Allen K. Sills, MD

None

None

None

None

None

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

None

Nam Tran, MD, PhD

None

None

None

None

None

David Tran, MD, PhD

Novocure

Novocure

Novocure

None

None

Sarika Trikha, PharmD

None

None

None

None

None

Frank D. Vrionis, MD, MPH, PhD

None

Florida Board of Medicine;
Orthofix;
Southeastern Brain Tumor Association

None

None

None

Patrick Yung Wen, MD

None

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eisai Inc.;
Exelixis Inc.;
Genentech, Inc.;
Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
MedImmune Inc.;
Merck & Co., Inc.;
Merck & Co., Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
EMD Serono;
Geron;
Vascular Biogenics;
sanofi-aventis U.S.

None

None

None